Literature DB >> 11425672

How to predict proliferative vitreoretinopathy: a prospective study.

R H Asaria1, C H Kon, C Bunce, D G Charteris, D Wong, P J Luthert, P T Khaw, G W Aylward.   

Abstract

PURPOSE: To determine prospectively the accuracy of a predictive risk formula for the development of postoperative proliferative vitreoretinopathy (PVR) when applied in a clinical setting.
DESIGN: Prospective noncomparative interventional case series. PARTICIPANTS: Two hundred nineteen subjects undergoing primary vitrectomy for rhegmatogenous retinal detachment were studied.
METHOD: By use of a formula-based discriminant rule, subjects were classified as either high or low risk for the development of PVR. All subjects were followed prospectively. OUTCOME MEASURES: Development of postoperative PVR as defined by the updated the Retina Society Classification.
RESULTS: Complete data were available on 212 of 219 subjects. There were 130 subjects identified as low risk and 82 subjects as high risk; 9.2% of the low-risk (12 of 130) compared with 28% (23 of 82) of the high-risk subjects had postoperative PVR develop. This difference was statistically significant (P < 0.001).
CONCLUSIONS: Our study has shown that using a clinical model it is possible to identify subjects at greater risk of PVR developing after primary vitrectomy.

Entities:  

Mesh:

Year:  2001        PMID: 11425672     DOI: 10.1016/s0161-6420(01)00553-x

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  15 in total

1.  Retinal detachment surgery in district general hospitals: an audit of changing practice.

Authors:  R Ling; C James; P Simcock; R Gray; S Shaw
Journal:  Br J Ophthalmol       Date:  2002-07       Impact factor: 4.638

Review 2.  Rhegmatogenous retinal detachment--an ophthalmologic emergency.

Authors:  Nicolas Feltgen; Peter Walter
Journal:  Dtsch Arztebl Int       Date:  2014-01-06       Impact factor: 5.594

3.  Early vitrectomy for fundus-obscuring dense vitreous haemorrhage from presumptive retinal tears.

Authors:  Narendra Dhingra; Ian Pearce; David Wong
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-02       Impact factor: 3.117

4.  Primary vitrectomy for rhegmatogenous retinal detachment: an analysis of 512 cases.

Authors:  Heinrich Heimann; Xiulan Zou; Claudia Jandeck; Ulrich Kellner; Nikolaos E Bechrakis; Klaus-Martin Kreusel; Horst Helbig; Lothar Krause; Andreas Schüler; Norbert Bornfeld; Michael H Foerster
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-07-26       Impact factor: 3.117

Review 5.  Proliferative Vitreoretinopathy: A Review.

Authors:  Sana Idrees; Jayanth Sridhar; Ajay E Kuriyan
Journal:  Int Ophthalmol Clin       Date:  2019

Review 6.  Minireview: Fibronectin in retinal disease.

Authors:  Charles G Miller; Greg Budoff; Jonathan L Prenner; Jean E Schwarzbauer
Journal:  Exp Biol Med (Maywood)       Date:  2016-10-20

7.  Non-buckled vitrectomy for retinal detachment with inferior breaks and proliferative vitreoretinophathy.

Authors:  Yan Sheng; Wen Sun; Bin Mo; Ya-Jie Yu; Yang-Shun Gu; Wu Liu
Journal:  Int J Ophthalmol       Date:  2012-10-18       Impact factor: 1.779

8.  Effect of intraoperative 5-fluorouracil and low molecular weight heparin on the outcome of high-risk proliferative vitreoretinopathy.

Authors:  Sunil Ganekal; Syril Dorairaj
Journal:  Saudi J Ophthalmol       Date:  2014-03-21

9.  [Densiron-68 heavy silicone oil in cases of PVR. Anatomic and functional outcomes].

Authors:  T Stappler; H Heimann; S K Gibran; C Groenewald; I A Pearce; D Wong
Journal:  Ophthalmologe       Date:  2009-04       Impact factor: 1.059

10.  Variations in Functional and Anatomical Outcomes and in Proliferative Vitreoretinopathy Rate along a Prospective Collaborative Study on Primary Rhegmatogenous Retinal Detachments: The Retina 1 Project-Report 4.

Authors:  J Carlos Pastor; Itziar Fernández; Rosa M Coco; María R Sanabria; Enrique Rodríguez de la Rúa; Rosa M Piñon; Vicente Martinez; Anna Sala-Puigdollers; José M Gallardo; Sara Velilla
Journal:  ISRN Ophthalmol       Date:  2012-10-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.